Claire M.
Filed with the SEC on · Summarized by InvestorsBot
Claire M. Fraser, Ph.D. appointed to Waters’ board effective Feb 9, 2026; Board size increased from 10 to 11 in connection with the closing of the Transactions per the Merger Agreement. She serves until the 2026 AGM. $WAT 🧪 #BoardUpdate #M&A
Waters’ Board determined Dr. Fraser meets NYSE independence standards; company reports no related‑party transactions requiring disclosure under Item 404(a) of Regulation S‑K. $WAT ⚖️ #CorporateGovernance #Disclosure
Dr. Fraser will receive standard non‑employee director pay plus an initial equity grant valued at $229,166 (50% restricted stock, 50% NQ stock options) vesting on the 1st anniversary of the Closing Date; prorated cash retainer, meeting fees & expenses. $WAT 💼📈 #Compensation #ExecPay